ETHOS ENGAGE: Enhancing Treatment of Hepatitis C in Opioid Substitution Settings
Recruiting
N/A
Interventional Study
Hepatitis C
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Health Services Research
- Participants needed
- 6,000 (estimated)
- Sponsor
- Kirby Institute · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The overall goals of the ETHOS II Project are to enhance hepatitis C virus (HCV) care in drug treatment clinics and needle and syringe programs (NSPs) in New South Wales and Australia, and to develop a translational framework for subsequent establishment of HCV screening and treatment programs in drug treatment clinics and NSPs across NSW and nationally.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Participant has voluntarily signed the informed consent form;
* 18 years of age or older;
* History of injecting drug use\*;
* Recent injecting drug use (previous six months) or currently receiving OST\*.
* These criteria will not apply for recruitment from residential reha…
Contacts